Dyadic International, Inc. (AMEX:DIL), a biotechnology company, announced today that its President and Chief Executive Officer, Mark Emalfarb...
Dyadic International, Inc. (AMEX:DIL), a biotechnology company, today announced financial results for the second quarter and six-months ended June...
Dyadic International, Inc. (AMEX:DIL), a biotechnology company, will report today at the Third Annual World Congress on Industrial Biotechnology...
Dyadic International, Inc. (AMEX:DIL), a biotechnology company, today announced financial results for the first quarter ended March 31, 2006. ?...
Dyadic International, Inc. (AMEX:DIL), a global biotechnology company, announced today that its President and CEO, Mark Emalfarb, will make a...
Dyadic International, Inc. (AMEX:DIL), a global biotechnology company (the "Company"), with subsidiaries in Hong Kong and mainland China, Poland...
Dyadic International, Inc. (AMEX:DIL), a biotechnology company, announced today that it has received approximately $2.1 million in proceeds from...
Dyadic International, Inc. (AMEX: DIL), a biotechnology company, announced today that Mark Emalfarb, CEO and Glenn Nedwin, Ph.D., Chief Scientific...
Dyadic International, Inc. (AMEX:DIL), a biotechnology company, announced today that it has engaged The Scripps Research Institute to work with...
Dyadic International, Inc. (AMEX:DIL), a biotechnology company, today announced financial results for the year ended December 31, 2005. ?...
Dyadic International, Inc. (AMEX:DIL), a biotechnology company, announced today that Glenn E. Nedwin, Ph.D., MBA, co-founder and President since...
Dyadic International, Inc. (AMEX:DIL), a biotechnology company engaged in the development, manufacture and sale of biological products, announced...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.